Neuroscience News

Juliet Knowles's research has recently shown that the brain can use adaptive myelination to perfect “skills” that are actually pathological, such as having s

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction.

Wu Tsai Neuro affiliate Michelle Monje and team discovered that adaptive myelination, a form of brain plasticity, contributes to drug addiction. A single morphine dose in mice triggered myelination in reward-related brain circuits, reinforcing drug-seeking behavior. Blocking this myelination prevented addiction, highlighting potential new treatment strategies.

A study in mice by Wu Tsai Neuro affiliate Michelle Monje and team has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

Students learned how behind every success is a story of perseverance, frustration, and failure in a fall quarter class featuring Stanford’s own Nobel laureates and MacArthur “genius” fellows, including Wu Tsai Neuro affiliate Michelle Monje.

With limited therapeutic options available, Wu Tsai Neuro affiliate Michelle Monje and team have turned to studying the growth patterns of brain tumors that occur in glial cells to identify new treatment avenues.

Members of Wu Tsai Neuro and the Knight Initiative were selected by the editors and writers of Stanford Communications for the most significant scientific achievements covered by Stanford Medicine in 2023.

In this episode, neuroscientist and pediatric oncologist Michelle Monje helps us understand the mystery of the persistent "brain fog" that often plagues Long COVID patients.

Wu Tsai Neuro faculty affiliate Michelle Monje, MD, PhD, was one of four Stanford Medicine faculty members elected to the prestigious National Academy of Medicine in 2021.

Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.